orantinib has been researched along with 2-aminopurine in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (2-aminopurine) | Trials (2-aminopurine) | Recent Studies (post-2010) (2-aminopurine) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 1,409 | 90 | 291 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerhard, M; Kalali, B; Mempel, M; Ollert, M; Ring, J; Seidl, B | 1 |
1 other study(ies) available for orantinib and 2-aminopurine
| Article | Year |
|---|---|
Thymic stromal lymphopoietin induction by polyinosinic:polycytidylic acid in human keratinocytes is preferentially mediated through protein kinase R and retinoid-inducible gene I and not Toll-like receptor 3.
Topics: 2-Aminopurine; Antimetabolites; Cells, Cultured; Cytokines; DEAD Box Protein 58; DEAD-box RNA Helicases; eIF-2 Kinase; Enzyme Inhibitors; Humans; Indoles; Interferon Inducers; Interferon-Induced Helicase, IFIH1; Keratinocytes; Macrolides; Oxindoles; Poly I-C; Propionates; Pyrroles; Receptors, Immunologic; Thymic Stromal Lymphopoietin; Toll-Like Receptor 3 | 2009 |